RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,517 | +706.0% | 41,565 | +594.4% | 0.00% | – |
| Q2 2023 | $39,268 | +659.1% | 5,986 | +592.0% | 0.00% | – |
| Q1 2023 | $5,173 | +284.6% | 865 | +49.9% | 0.00% | – |
| Q4 2022 | $1,345 | -97.7% | 577 | -96.7% | 0.00% | – |
| Q3 2022 | $59,000 | -1.7% | 17,559 | -21.9% | 0.00% | – |
| Q2 2022 | $60,000 | -50.4% | 22,480 | -45.0% | 0.00% | – |
| Q1 2022 | $121,000 | -57.1% | 40,878 | +24.0% | 0.00% | – |
| Q4 2021 | $282,000 | +112.0% | 32,964 | +84.5% | 0.00% | – |
| Q3 2021 | $133,000 | +504.5% | 17,867 | +668.1% | 0.00% | – |
| Q2 2021 | $22,000 | – | 2,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |